G

Genincode PLC
LSE:GENI

Watchlist Manager
Genincode PLC
LSE:GENI
Watchlist
Price: 2.5 GBX 11.11% Market Closed
Market Cap: 7.2m GBX

Wall Street
Price Targets

GENI Price Targets Summary
Genincode PLC

There are no price targets for GENI.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Genincode PLC Competitors:
Price Targets
CCRN
Cross Country Healthcare Inc
41% Upside
AHX
Apiam Animal Health Ltd
30% Upside
HEALTH
Nightingale Health Oyj
24% Downside
CHE
Chemed Corp
25% Upside
FLRY3
Fleury SA
17% Upside
PINC
Premier Inc
4% Upside
VOX
Voxel SA
10% Downside
HIMS
Hims & Hers Health Inc
21% Upside

Revenue
Forecast

Revenue Estimate
Genincode PLC

For the last 3 years the compound annual growth rate for Genincode PLC's revenue is 33%. The projected CAGR for the next 2 years is 225%.

33%
Past Growth
225%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Genincode PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Genincode PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-68%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GENI's stock price target?
Not Available

GENI doesn't have any price targets made by Wall Street professionals.

What is Genincode PLC's Revenue forecast?
Projected CAGR
225%

For the last 3 years the compound annual growth rate for Genincode PLC's revenue is 33%. The projected CAGR for the next 2 years is 225%.

Back to Top